Funding for this research was provided by:
Science Foundation Ireland (15/BIAP/3185, 12/1A/1294)
Irish Cancer Society (CCRC13GAL)
Breast Cancer NOW (2018JulPR1094, 2019AugSF1310)
Received: 16 June 2020
Accepted: 2 October 2020
First Online: 19 November 2020
Ethics approval and consent to participate
: All patient clinical material was collected under the clinical trial NCT01840293 (ExternalRef removed, CTRIAL-IE 09/07) following ethical approval from Beaumont Hospital Medical Research Ethics Committee. All patients were fully consented onto the trial. All animal experiments were performed in accordance with the EU Directive 210/63/EU and were reviewed and approved by Research Ethics Committee, RCSI under licence from The Health Products Regulatory Authority. Experiments were undertaken in accordance with the Arrive Guidelines where appropriate.
: Not applicable.
: The authors declare that they have no competing interests. LY has previously had collaborative funding with Pfizer from Science Foundation Ireland.